SCHEMBL8259253

SCHEMBL8259253

CC1CCN(C(=O)C=O)CC1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.50
▸ NPC1 O15118 3/20 0.50
▸ ACHE P22303 1/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ HPGD P15428 4/20 0.45
▸ LMNA P02545 3/20 0.45
▸ GAA P10253 2/20 0.45
▸ PHGDH O43175 1/20 0.43
▸ MGLL Q99685 1/20 0.43
▸ RAB9A P51151 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ MAOB P27338 1/20 0.41
▸ GRM5 P41594 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.39
▸ GABRA1 P14867 1/20 0.38
▸ GABRB2 P47870 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14999471 0.80 ALDH1A1 (0.48) ALDH1A1NPC1ACHEMEN1KMT2A
SCHEMBL463245 0.80 ALDH1A1 (0.48) ALDH1A1NPC1ACHEMEN1KMT2A
SCHEMBL14562577 0.79 NPC1 (0.39) NPC1LMNAGAARAB9ASMN1; SMN2
SCHEMBL24089737 0.78 HPGD (0.50) ALDH1A1NPC1ACHEMEN1KMT2A
SCHEMBL25365606 0.78 HPGD (0.50) ALDH1A1NPC1ACHEMEN1KMT2A
SCHEMBL14562667 0.77 L3MBTL3 (0.53) NPC1MEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL25446918 0.75 ALDH1A1 (0.58) ALDH1A1NPC1ACHEMEN1KMT2A
SCHEMBL25200465 0.74 ALDH1A1 (0.43) ALDH1A1NPC1ACHEMEN1KMT2A
SCHEMBL22296232 0.74 ALDH1A1 (0.43) ALDH1A1NPC1ACHEMEN1KMT2A
SCHEMBL17228557 0.74 ALDH1A1 (0.43) ALDH1A1NPC1ACHEMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006097293-A2 COMBINATION OF A STEROID SULFATASE INHIBITOR AND AN ASCOMYCIN NOVARTIS AG (CH) 2006-09-21 — — WO disclosed
Send feedback